Today, global biosimulation leader Certara Inc. (NASDAQ: CERT) is rising in premarket trading, up 5.01% to trade at $33.32 at the time of last check-in premarket trading. Yesterday, Certara shares closed the day out at $31.73, giving the stock a -0.25% decline.
CERT stock traded 0.26 million shares compared to the average of 688.68K shares. A price range of $31.19 to $32.54 was seen for CERT stock during the trading session. Prior to this week’s release of quarterly results, the CERT stock is gaining traction.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
- Looking For The Best Stocks To Buy For 2021? 3 Electric Vehicle Stocks To Watch
- Top 3 Cosmetics Stocks in the market
When CERT will release financials?
Certara takes medicine research and development to the next level with biosimulation software and technology. In addition to the more than 1,650 global biopharmaceutical companies and leading academic institutions, key regulatory agencies in 61 countries employ CERT.
Certara recently announced that it will release preliminary first-quarter financial results after the market closes on May 6, 2021. CERT Management will hold a conference call at 5:00:00 p.m. ET to discuss the financial results on that day.
BofA Securities 2021 Virtual Health Care Conference is another event Certara (CERT) will participate in. CERT’s CEO, William Feehery, and CFO, Andrew Schmick, are scheduled to present at 2:45 p.m. ET on May 11, 2021. A live webcast will be broadcasted at CERT’s website and are expected to remain for 90 days afterward.